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Accumulation of long-chain bases in yeast promotes their
conversion to a long-chain base vinyl ether
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Department of Biology,* University of Fribourg, 1700 Fribourg, Switzerland; and Department of Internal
Medicine,† Washington University School of Medicine, St. Louis, MO 63110
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Sphingolipids are an essential class of lipids greatly enriched in the plasma membrane of eukaryotic cells. They
have been implicated in the formation and maintenance of
lateral membrane domains, important for protein sorting
and signaling along the compartments of the secretory pathway. Apart from these structural roles, their biosynthetic precursor and intermediates, such as long-chain bases (LCBs)
and ceramide, exert important signaling functions to coordinate complex processes, for example, cell cycle progression,
apoptosis, and inflammation. Hence, the synthesis and turnover of these lipids must be precisely controlled (1–3).
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Sphingolipid synthesis starts in the endoplasmic reticulum (ER), where serine palmitoyl-CoA transferase (SPT)
catalyzes the first step in formation of LCBs (4). Variations
in chain length of the condensing acyl-CoA and the incorporation of alternative amino acids can result in the synthesis of a chemically heterogeneous set of sphingoid bases
(5, 6). The activity of SPT, the rate-limiting enzyme of the
pathway, is negatively regulated by Orm proteins, conserved integral ER membrane proteins whose phosphorylation relieves inhibition of SPT activity (7, 8). Kinases that
phosphorylate Orm proteins thus integrate multiple signals to maintain sphingolipid homeostasis, including heat
and ER stress, and availability of nutrients (9–13).
The major LCBs in yeast are dihydrosphingosine (DHS)
and phytosphingosine (PHS), which upon ceramide formation condense with a CoA-activated C26 very long-chain
fatty acid (14, 15). This reaction is catalyzed by the ERlocalized ceramide synthase (CerS). Upon transport to the
Golgi apparatus, ceramides are converted to a set of complex sphingolipids: inositol phosphorylceramide, mannosylinositol phosphorylceramide, and mannosyl-diinositol
phosphorylceramide (16–19).
In addition to these biosynthetic routes, complex sphingolipids, ceramide, and LCBs are also subject to degradation. Complex sphingolipids are cleaved by an inositol
phosphosphingolipid phospholipase C, Isc1 (20). Ceramide,
on the other hand, is degraded through alkaline ceramidases Ydc1 and Ypc1 (21, 22). Phosphorylated LCBs, finally,
can be cleaved by a sphingosine-1-phosphate lyase, Dpl1, to
ethanolamine phosphate and fatty aldehyde (23). The activity of components of this degradative branch, Isc1, Ydc1,
and Ypc1, is controlled by the target of rapamycin complex 1
Abbreviations: CerS, ceramide synthase; DHS, dihydrosphingosine;
ER, endoplasmic reticulum; LCB, long-chain base; OD, optical density;
PHS, phytosphingosine; SPT, serine palmitoyl-CoA transferase; YPD,
yeast peptone dextrose.
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Abstract Long-chain bases (LCBs) are the precursors to ceramide and sphingolipids in eukaryotic cells. They are formed
by the action of serine palmitoyl-CoA transferase (SPT), a complex of integral membrane proteins located in the endoplasmic reticulum. SPT activity is negatively regulated by Orm
proteins to prevent the toxic overaccumulation of LCBs. Here
we show that overaccumulation of LCBs in yeast results in their
conversion to a hitherto undescribed LCB derivative, an LCB
vinyl ether. The LCB vinyl ether is predominantly formed from
phytosphingosine (PHS) as revealed by conversion of odd
chain length tracers C17-dihydrosphingosine and C17-PHS
into the corresponding LCB vinyl ether derivative. PHS vinyl
ether formation depends on ongoing acetyl-CoA synthesis, and
its levels are elevated when the LCB degradative pathway is
blocked by deletion of the major LCB kinase, LCB4, or the
LCB phosphate lyase, DPL1. PHS vinyl ether formation thus
appears to constitute a shunt for the LCB phosphate- and lyasedependent degradation of LCBs. Consistent with a role of
PHS vinyl ether formation in LCB detoxification, the lipid is
efficiently exported from the cells.—Martínez-Montañés, F.,
M. A. Lone, F-F. Hsu, and R. Schneiter. Accumulation of longchain bases in yeast promotes their conversion to a long-chain
base vinyl ether. J. Lipid Res. 2016. 57: 2040–2050.
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(24). Importantly, the transient intermediates of the pathway, LCB, LCB phosphate, and ceramide, not only act as
biosynthetic precursors but also have important signaling
functions in stress response (see Fig. 1A for an overview of
the pathway) (25, 26).
Here we describe a novel LCB derivative, identified as an
LCB vinyl ether. This LCB vinyl ether is generated mainly
from PHS in cells that accumulate high levels of LCBs either due to deregulated de novo synthesis, a block in the
degradative pathway, or uptake of externally provided PHS.
Conversion of PHS to the vinyl ether derivative appears to
act as a shunt for the catabolic pathway because PHS vinyl
ether levels are greatly elevated in mutants that cannot
phosphorylate LCBs or in mutants lacking the sphingosine1-phosphate lyase. Consistent with a potential role in PHS
detoxification, the PHS vinyl ether is excreted from cells.

(San Jose, CA) LTQ Orbitrap Velos mass spectrometer with Xcalibur operating system. Purified compound in methanol was infused (1.5 l/min) to the ESI source, where the skimmer was set
at ground potential, the electrospray needle was 4.0 kV, and temperature of the heated capillary was set at 300°C. The automatic
gain control of the ion trap was set to 5 × 104, with a maximum
injection time of 50 ms. Helium was used as the buffer and collision gas at a pressure of 1 × 103 mbar (0.75 mTorr). The MSn
experiments were carried out with an optimized relative collision
energy ranging from 20% to 35% with an activation q value of
0.25 and the activation time of 10 ms to leave a minimal residual
abundance of precursor ion (20%). The mass selection window
for the precursor ions was set at 1 Da wide to admit the monoisotopic ion to the ion-trap for CID for unit resolution detection in
the ion-trap or high-resolution accurate mass detection in the Orbitrap mass analyzer. Mass spectra were accumulated in the profile mode, typically for 2 to 10 min for MSn spectra (n = 2,3,4).

Yeast strains and growth conditions
Yeast strains and their genotypes are listed in supplemental
Table S1. Strains were cultivated in yeast peptone dextrose (YPD)-rich
medium (1% Bacto yeast extract, 2% Bacto peptone; US Biological,
Swampscott, MA) or synthetic dextrose medium lacking uracil
(SD-URA) synthetic medium (0.67% yeast nitrogen base without
amino acids; US Biological, Salem, MA), 2% glucose, and the following amino acids: 20 mg/l of each adenine, arginine, histidine,
methionine, and tryptophan; 60 mg/l leucine, 230 mg/l lysine,
and 300 mg/l threonine. Double-mutant strains were generated
by crossing of single mutants and by gene disruption, using PCR
deletion cassettes and a marker rescue strategy (27). Myriocin
(Sigma Aldrich, St. Louis, MO) was diluted in DMSO and used
from a 1,000× stock, and Fumonisin B1 (Enzo Life Sciences,
Farmingdale, NY) was diluted in water and used from a 5× stock.
Sphingosine, 1-deoxysphinganine, C18-d-erythro-DHS, C2-dihydroceramide, C17/C18-DHS, and C17/C18-PHS were obtained
from Avanti (Avanti Polar Lipids, Alabaster, AL); l-threo-DHS
and 2-deoxyglucose were from Sigma.

Lipid extraction and analysis by MS
For lipid analysis, overnight cultures of strains were diluted into
fresh YPD (Figs. 1B, 2, 3, 4, 5A, 7A) or SD-URA (Fig. 5B, 6B, 7B)
media, and cells were grown at 30°C to an optical density (OD)600nm
of approximately 2. Temperature-sensitive strains were grown at
24°C in YPD (Fig. 7A). Lipids were extracted from 10 OD600nm
units of cells with CHCl3 and methanol (2:1 by volume) or from
the culture supernatant with 2 vol of diethyl ether. C17-DHS
(1 nmol) was used as internal standard (28). LCBs were analyzed
in the positive ion mode on a Bruker Esquire HCT ion trap mass
spectrometer using ESI at a flow rate of 180 ml/h and a capillary tension of 250 V. Ion fragmentation was induced by argon
case collision at a pressure of 8 mbar. [M + H]+ ions of DHS, PHS,
and the corresponding vinyl ether derivatives were quantified
relative to the internal standard. Statistical significance of data was
analyzed by a multiple t-test (GraphPad Prism, La Jolla, CA).

Structural characterization of the vinyl ether by
high-resolution MS
Structural identification using low-energy collision-induced
n
dissociation (CID) linear ion trap (LIT) MS with high-resolution
(R = 100,000 at m/z 400) MS was conducted on a Thermo Scientific

Identification and characterization of a PHS vinyl ether
In the course of analyzing LCB levels by MS in lipid extracts from various yeast mutants, we noticed an uncharacterized peak at m/z 344.3. This lipid was of low abundance
in wild-type cells (25 pmol/OD), but its concentration was
greatly elevated in elo3 mutant cells (436 pmol/OD; Fig.
1B, C). Elo3 is a component of the ER-associated acyl chain
elongase complex required for the synthesis of C26 very
long-chain fatty acids (29, 30). elo3 mutant cells make C22
instead of the normal C26 fatty acids. Shorter acyl-CoAs,
however, are a poor substrate for CerS, the enzyme that
catalyzes the N-acylation of LCBs to form ceramide (31,
32). As a consequence, elo3 mutant cells display greatly
elevated levels of PHS. While wild-type cells have about 19
pmol/OD of PHS, elo3 mutant cells have up to 451 pmol/
OD of PHS. The fact that the relative abundance of the
lipid at m/z 344.3 correlated with the abundance of PHS in
wild-type and elo3 mutant cells suggested that it might be
derived from PHS.
To test this hypothesis, we characterized the structure of
this lipid by high-resolution MS. When subjected to ESI in
the positive-ion mode, [M + H]+ ions were observed at m/z
344.3164, which corresponds to an elemental composition
of C20H42O3N (calculated m/z = 344.3159). In the negativeion mode, ions at m/z 342.3014, corresponding to an
elemental composition of C20H40O3N (calculated m/z =
342.3013), were observed. These results indicate that the
compound had an elemental composition of C20H41O3N,
representing a 1-O-ethenyl-2-amino-4-octadecene-1,3-diol,
that is a PHS derivative containing a vinyl ether at the C1
hydroxyl group of PHS (Fig. 2).
Fragmentation (MS2) of the [M + H]+ ions at m/z
344.3164 gave rise to ions of 326 and 308, arising from consecutive losses of water (Fig. 2A, route a), along with ions of
m/z 300 arising from loss of CH2=CHOH, and ions of m/z
282 (300 - H2O), arising from an additional loss of water
(supplemental Fig. S1). Two pathways leading to the elimination of CH2=CHOH are proposed. The first pathway involves
the participation of the hydrogen of the 3-OH group to
Synthesis of a long-chain base vinyl ether in yeast
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Fig. 1. Identification of a putative LCB derivative. A: Schematic overview of the yeast sphingolipid biosynthetic and degradative pathways. Key enzymes and lipid intermediates are shown. Mutants used in this study
are indicated in bold, and drugs that were used are shown in red. The pathway leading to dihydroceramide is
highlighted in orange, the maturation of phytoceramide to the complex sphingolipids is highlighted in
green, and the degradative pathway is highlighted in blue. B, C: ESI/MS profile of LCBs present in wild-type
(WT; B) and elo3 (C) mutant cells. Lipid extracts prepared from wild-type and elongase (elo3) mutant cells
were analyzed by ESI/MS in the positive ion mode using the odd chain-length C17-DHS (m/z 288.3) as internal
standard (indicated in blue). The major PHS species present in both strains, C18-PHS (m/z 318.3) is indicated
in green. The [M + H]+ ion at m/z 344.3, indicated in red, represents a putative novel LCB derivative.
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form a long alkyl chain with a terminal oxetane species of
m/z 300 (Fig. 2A, route b), which gave rise to ions of m/z
282 via further loss of water (Fig. 2A, route b1). The second
pathway involves the hydrogen of the secondary amino
group, leading to the formation of an alkyl chain with a
terminal aziridine (Fig. 2A, route c), which undergoes further loss of water to yield ions of m/z 282 (Fig. 2A, route
c1). These fragmentation pathways were further supported
by MS3 spectrum of the ions of m/z 282 (344 → 282; supplemental Fig. S1B), which is identical to the MS4 spectrum of
m/z 282 (344 → 326 → 282; data not shown). The spectrum

(supplemental Fig. S1B) also contained ions of m/z 265
and 252 arising from losses of NH3 (Fig. 2A, route b2,
structures highlighted in blue) and HCHO (Fig. 2A, route
b3), respectively. The ion of m/z 264 is a hallmark of the
sphingosine LCB structure and arises from loss of water
from the aziridine precursor ions (Fig. 2A, route c2, structures highlighted in orange) (33, 34). The above fragmentation processes were supported by high resolution MS,
from which the deduced elemental composition of the
fragment ions are consistent with the suggested structures
(data not shown).
Synthesis of a long-chain base vinyl ether in yeast
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Fig. 2. High-resolution MS and fragmentation analysis indicate that the putative LCB derivative is a LCB vinyl ether. Lipid extract from
elo3 mutant cells were subject to high-resolution MS and MSn analysis. A: Fragmentation scheme of the putative LCB derivative [M + H]+ at
m/z 344.3 in the positive ion mode. The structure of the LCB vinyl ether is highlighted in yellow, and the structures and m/z of the observed
product ions are indicated by the arrows. Fragmentation along route c gives rise to the structures indicated in orange, and fragmentation
along routes b1 and b2 gives rise to the structure indicated in blue. B: Fragmentation scheme of the putative LCB derivative [M – H] at m/z
342.3 in the negative ion mode.
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The structural assignment was further supported by high
resolution LIT MSn of the corresponding [M – H] ions
(Fig. 2B). The MS2 spectrum of the [M – H] ion at m/z 342
contained ions at m/z 324 and 306 arising from consecutive
losses of water, and prominent ions of m/z 255, arising from
cleavage of C3(OH)-C2(NH2) bond of the LCB, together
with ions of m/z 225 arising from cleavage of the C3(OH)C4(OH) bond (35) (supplemental Fig. S2A). The cleavage
of this latter bond is consistent with the formation of the
ions of m/z 116, in which the anionic charge site is located
at the oxygen atom attached to C3 of the LCB (Fig. 2B).
The presence of the ions of m/z 116 also supports the notion of the presence of the 1-O-ethenyl group in the molecule. Further dissociation of the ions of m/z 255 (342 →
255; supplemental Fig. S2B) gave rise to the terminally conjugated ions of m/z 253 via loss of H2, the prominent ions of
m/z 225 arising from loss of HCHO, and ions of m/z 237
by loss of water. The MS4 spectrum of the ions of m/z 225
(342 → 255 → 225; supplemental Fig. S2C) are dominated
2044
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by ions of m/z 223 and 221 representing a terminally conjugated diene and triene, respectively, arising from consecutive losses of H2. The spectrum also contained ions at m/z
197, 183, 169, 155, and so forth, and at m/z 111, 97, 83,
arising from cleavages of the C-C bond of the LCB via
charge-remote fragmentation (Fig. 2B). These results are
consistent with the assignments of the suggested structure
of 1-O-ethenyl-2-amino-4-octadecene-1,3-diol.
We note that the structure of the proposed PHS vinyl
ether has the same elemental composition as C2-dihydroceramide and is thus isobaric with C2-dihydroceramide. The
fragmentation pattern of the PHS vinyl ether in both positive and negative ion mode, however, is clearly distinct
from that of C2-dihydroceramide (supplemental Fig. S3).
Fragmentation of acetylated LCBs typically results in a
characteristic loss of m/z 42, corresponding to the loss of a
ketene (supplemental Fig. S3). This is not observed upon
fragmentation of PHS vinyl ether, which instead loses a
fragment of m/z 44, corresponding to a vinyl alcohol. Thus,

Downloaded from www.jlr.org at Washington Univ Medical Library, on November 27, 2016

Fig. 3. The LCB vinyl ether is predominantly produced from PHS. A: PHS but not DHS is efficiently
converted to the vinyl ether derivative. Lipids were extracted from elo3 and elo3 sur2 double mutant
cells and LCBs were analyzed by ESI/MS with C17DHS as an internal standard. elo3 mutant cells have
about equimolar levels of both PHS and PHS vinyl
ether. elo3 sur2 double mutant cells accumulate
high levels of DHS but show only low levels of the
corresponding DHS vinyl ether. B: Externally added
PHS but not DHS is efficiently converted to the PHS
vinyl ether. Wild-type cells were grown to OD 2 and
supplemented with 10 µM of the indicated LCB for
30 min, lipids were extracted and analyzed by ESI/MS.
The ratio of the externally added LCB to the corresponding vinyl ether derivative is blotted. Values represent means ± SD of three independent determinations.
n.d.; not detectable.
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the fragmentation pattern of the PHS vinyl ether is not
compatible with that of either an N- or O-acetylated LCB,
including C2-dihydroceramide.
PHS is efficiently converted to PHS vinyl ether
To confirm this structural assignment and to test whether
DHS could also be converted to a DHS vinyl ether, we analyzed the formation of the LCB vinyl ether in cells that cannot form PHS due to a deletion of the Sur2 hydroxylase,
which converts DHS into PHS (36). Compared with elo3
mutant cells, the elo3 sur2 double mutant had greatly
elevated levels of DHS. Despite these elevated DHS levels,
the elo3 sur2 double mutant produces only very low
levels of the corresponding DHS vinyl ether. PHS, accumulating in the elo3 single mutant, however, is efficiently
converted to the PHS vinyl ether as elo3 mutant cells display about equal levels of both PHS and PHS vinyl ether
(Fig. 3A). We thus conclude that PHS rather than DHS
is the preferred substrate for formation of the LCB vinyl
ether.
To test whether conversion of PHS to the vinyl ether derivative is a general reaction of cells to high levels of PHS,
we challenged wild-type cells with externally added LCBs.

Wild-type cells incubated with 10 µM PHS during 30 min
displayed high levels of PHS vinyl ether. In these cells, levels of PHS vinyl ether were 1.7-fold higher than free PHS
levels (Fig. 3B). Cells incubated with DHS, however, displayed only low levels of the DHS vinyl ether, supporting
the conclusion that PHS is the preferred substrate for formation of the LCB vinyl ether.
To distinguish between the conversion of internally synthesized LCBs and that of externally added LCBs to the vinyl ether, we challenged cells with a synthetic, odd chain
length LCB tracer. We have previously shown that these
C17-LCBs are efficiently taken up and incorporated into
ceramide and complex sphingolipids (28). Wild-type cells
converted C17-PHS efficiently to the C17-PHS vinyl ether,
whereas C17-DHS was only inefficiently transformed to the
C17-DHS vinyl ether (Fig. 3B). Other LCBs, such as sphingosine, or the stereoisomer of the natural DHS, l-threoDHS, were also only very inefficiently converted to the
corresponding vinyl ether derivatives. Deoxysphinganine,
on the other hand, was not converted to the vinyl ether,
which is consistent with the fact that the vinyl ether group
is bound to the C1 hydroxyl group, which is missing in deoxysphinganine. Taken together, these results thus show
Synthesis of a long-chain base vinyl ether in yeast
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Fig. 4. Elevated levels of PHS provoke the accumulation of PHS vinyl ether. A: Mutants that accumulate high levels of PHS also display high
levels of the vinyl ether derivative. Lipids were extracted from cells of the indicated genotypes and LCB levels were quantified by ESI/MS.
For the myriocin treatment, orm1 orm2 double mutant cells were incubated with 1 µg/ml myriocin for 4 h. B: Inhibition of SPT activity by
myriocin leads to a simultaneous decrease in free PHS and PHS vinyl ether levels. elo3 mutant cells were treated with 5 µg/ml myriocin for
4 h, and LCB levels were quantified by ESI/MS. C: Pharmacologic and genetic disruption of ceramide synthesis results in elevated levels of
PHS vinyl ether. Wild-type cells were treated with 200 µM of fumonisin B1, an inhibitor of CerS, for 4 h, and PHS vinyl ether levels were
quantified by ESI/MS. lag1 lac1 double mutants lacking two components of the CerS have elevated levels of PHS vinyl ether. D: Conditional mutants in fatty acid elongation display elevated levels of C18- and C20-chain length PHS vinyl ethers. Cells that express the essential
3-hydroxyacyl-CoA dehydratase, PHS1, from a tetracycling repressible promoter (TET-PHS1) were cultivated in rich media, in which the
promoter is only weakly active, lipids were extracted, and LCB levels quantified by ESI/MS. Values represent means ± SD of three independent determinations. Asterisks denote statistical significance (* P < 0.05; ** P < 0.001; *** P < 0.0001).
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that both internally as well as externally provided PHS are
efficiently converted to the vinyl ether and that the levels of
free PHS and those of PHS vinyl ether reach similar levels
irrespective of whether PHS is endogenously synthesized
or whether it is taken up by the cells. DHS, on the other
hand, is not efficiently converted to the DHS vinyl ether,
indicating that the converting enzyme(s) has high substrate specificity for PHS over DHS.
PHS vinyl ether levels parallel those of free PHS
To test whether mutants other than elo3 known to accumulate high levels of internal PHS also show elevated
levels of PHS vinyl ether, we analyzed the levels of these two
LCBs in mutants that have deregulated SPT activity. Orm
proteins are conserved integral membrane proteins of the
ER that negatively regulate SPT activity and orm1 orm2
double mutants show greatly increased LCB levels (7, 8).
Consistent with this notion, the orm1 orm2 double mutant had greatly elevated levels of both PHS and PHS vinyl
ether (Fig. 4A). Deletion of the LCB-phosphate phosphatase, Lcb3, in the orm1 orm2 double mutant has previously
been shown to rescue the orm mutant from the detrimental accumulation of PHS (8). Lcb3 is an ER-localized
2046
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Fig. 6. PHS vinyl ether synthesis depends on acetyl-CoA production.
A: Possible reaction sequence for the biosynthesis of a PHS vinyl ether,
starting with an acetylated PHS, which is stepwise reduced to the vinyl
ether derivative. B: Acetyl-CoA synthesis is required for synthesis of the
PHS vinyl ether. Wild-type and acetyl-CoA synthase mutants (acs2,
acs1 acs2) carrying either and empty vector (+vector) a plasmidborne wild-type copy of ACS2 (+pACS2) or a temperature-sensitive allele (+pACS2-1ts) were grown at 24°C or shifted to 37°C for 2 h. Cells
were incubated with 10 µM C18-PHS for 30 min, and LCBs were extracted and quantified. Values represent means ± SD of three independent determinations. Asterisks denote statistical significance (* P <
0.05; ** P < 0.001; *** P < 0.0001). n.s.; not significant.

phosphatase that dephosphorylates exogenously imported
LCB phosphates, and this activity is necessary for the incorporation of exogenous LCBs into sphingolipids (21, 37–
39). Levels of free PHS and those of PHS vinyl ether were
reduced to wild-type concentrations upon deletion of Lcb3
in the orm1 orm2 double mutant (Fig. 4A). Similarly,
upon inhibition of SPT activity by myriocin, both PHS and
PHS vinyl ether levels were significantly reduced in both
orm1 orm2 and elo3 mutant cells (Fig. 4A, B).
Consistent with the notion that levels of the vinyl ether
parallel those of the free PHS, wild-type cells treated with
the CerS inhibitor fumonisin B1, which results in increased
PHS levels, displayed a slight but significant increase in
PHS vinyl ether levels (28) (Fig. 4C). Deletion of the catalytic components of the CerS, Lag1 and Lac1, on the other
hand, resulted in very high levels of PHS vinyl ether, consistent with the fact that lag1 lac1 double mutant cells have
high levels of free PHS (14) (Fig. 4C). Repression of the

Downloaded from www.jlr.org at Washington Univ Medical Library, on November 27, 2016

Fig. 5. Blocking the degradation of either free or phosphorylated
LCBs results in the overaccumulation of PHS vinyl ether. A: elo3 mutant cells and double mutants of elo3 with either the major LCB kinase, lcb4, or the minor kinase, lcb5, were grown overnight to mid
exponential phase in YPD media, lipids were extracted, and the indicated LCB levels were quantified by ESI/MS. B: elo3 mutant cells and
elo3 dpl1 double mutant cells, lacking the LCB phosphate lyase, carrying either an empty vector (+vector) or a plasmid overexpressing the
LCB phosphatase LCB3 (+pLCB3) were grown in selective media, lipids were extracted, and LCB levels were quantified. Values represent
means ± SD of three independent determinations. Asterisks denote
statistical significance with respect to elo3 mutant cells (* P < 0.05;
** P < 0.001; *** P < 0.0001). n.s.; not significant.
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the possibility that the vinyl ether acts as an inert storage
form for the free LCB. In addition, the fact that LCBs of
different chain length are converted to the respective vinyl
ether indicates that the converting enzymes do not discriminate between these chain length variants of PHS.

essential component of the acyl chain elongase, PHS1,
which codes for a 3-hydroxyacyl-CoA dehydratase, through
a tetracycling regulatable promoter (TET-PHS1), again resulted in high levels of the C18-PHS vinyl ether and also
showed high levels of both C20-PHS and the C20-PHS vinyl
ether (30, 40, 41) (Fig. 4D). It is interesting to note that
lag1 lac1 double mutant cells and TET-PHS1 cells have
previously been shown to accumulate abnormally polar ceramides, as shown by TLC analysis of lipids labeled with
[3H]DHS or [14C]serine (14, 15, 41). Given the very high
levels of PHS vinyl ether produced in these cells, it is possible that the lipids identified as ceramide in these studies
actually was the PHS vinyl ether. The presence of the vinyl
ether group renders PHS so hydrophobic that it migrates
close to ceramide (our unpublished observations).
Taken together, these results indicate that the levels of
the vinyl ether consistently parallel those of the free PHS
under the various conditions tested here, indicating that
the half-life of the two lipids are similar, arguing thus against

PHS vinyl ether formation depends on ongoing
acetyl-CoA synthesis
To examine how the PHS vinyl ether is synthesized, we
hypothesized that PHS may first be acetylated and the ketone
group may subsequently be reduced, first to the hydroxyl
Synthesis of a long-chain base vinyl ether in yeast
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Fig. 7. The LCB vinyl ether is actively exported into the culture
medium. A: A substantial fraction of PHS vinyl ether is excreted into
the culture medium. PHS and PHS vinyl ether levels were quantified in the cell pellet and the culture supernatant of tsc13-1 elo3
double mutant cells. B: Export of PHS and PHS vinyl ether is energy
dependent. dpl1 mutant cells overexpressing the putative LCB
transporter, RSB1, were incubated with 10 µM of C17-PHS for
20 min, cells were washed in media containing 1 mg/ml defatted
BSA, and ATP levels were depleted by switching cells to medium
containing 2-deoxyglucose instead of glucose and NaN3/NaF (10
mM) for 15 min. Lipids were then extracted and quantified from the
cell pellet and the culture medium. Released LCB levels are expressed
as percentage of total LCBs. Asterisks denote statistical significance (*
P < 0.05; ** P < 0.001; *** P < 0.0001). n.s.; not significant.

PHS vinyl ether formation acts in parallel to the
degradative pathway
LCBs enter the degradative pathway by first being phosphorylated by either Lcb4 or Lcb5, the two LCB kinases in
yeast. Lcb4 is the major kinase located in the ER, whereas
Lcb5 has only minor activity in exponentially growing cells
(42, 43). The resulting LCB-phosphates (LCB-P) can then
either be dephosphorylated by Lcb3/Ysr3 or they are
cleaved by the LCB-P lyase, Dpl1, to ethanolamine phosphate and 1-hexadecanal (23). To test whether formation
of the vinyl ether depends on prior phosphorylation of the
LCB or whether it acts in parallel to this catabolic pathway,
we analyzed LCB levels in double mutants of elo3 with either lcb4 or lcb5. Deletion of these LCB kinases in the
elo3 mutant background resulted in slightly elevated levels of DHS and PHS (Fig. 5A). Deletion of the main LCB
kinase, Lcb4, in the elo3 mutant background, however,
resulted in a dramatic accumulation of PHS vinyl ether,
suggesting that a block in the catabolic pathway shunts
PHS toward the formation of the vinyl ether derivative. Deletion of the minor kinase activity, Lcb5, on the other hand,
did not significantly increase vinyl ether levels (Fig. 5A).
Given that blocking the degradative pathway through deletion of the major LCB kinase Lcb4 resulted in greatly elevated levels of PHS vinyl ether, we examined whether
deletion of the lyase would lead to a similar increase in PHS
vinyl ether levels. Deletion of Dpl1 in an elo3 mutant background again gave rise to slightly elevated levels of DHS and
PHS; PHS vinyl ether levels, however, were not significantly
increased. Upon overexpression of the LCB phosphate
phosphatase, Lcb3, however, PHS vinyl ether levels became
significantly elevated (Fig. 5B). Overexpression of Lcb3 is
expected to reduce the efficiency of the degradative pathway and hence to further increase levels of free LCBs. The
fact that this resulted in accumulation of PHS vinyl ether is
thus consistent with a shunt function of the pathway, which
diverges free PHS into formation of the vinyl ether.
Taken together, these data indicate that vinyl ether synthesis is independent of the degradative pathway and that
it acts in parallel to the catabolic pathway, possibly as a
shunt for the degradative pathway under conditions of
great excess of free intracellular LCBs. In addition, this
shunt is possibly important to prevent the detrimental accumulation of LCB-phosphate (44, 45). On the other
hand, the presence of the vinyl group on the C1 hydroxyl
shield this LCB derivative from phosphorylation and subsequent degradation through the lyase pathway.
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The PHS vinyl ether is excreted into the culture medium
Given that a PHS vinyl ether is considerably more hydrophobic than PHS itself, we wondered whether synthesis of
the vinyl ether derivative might be a means to detoxify the
cells from the detrimental effects of high PHS levels. We
thus analyzed PHS and PHS vinyl ether levels in the cell
pellet and the culture supernatant of elongase double mutant cells, tsc13-1 elo3, which have high levels of free PHS
and PHS vinyl ether (Fig. 7A). TSC13 encodes for the enoyl
reductase that catalyzes the last step in each very long-chain
fatty acid elongation cycle (53). Interestingly, PHS and
PHS vinyl ether levels present in the cell pellet were similar
to the levels of these two lipids present in the culture supernatant, indicating that both of these LCBs can be exported
by the cells. PHS vinyl ether levels, however, far exceeded
PHS levels in both the cell pellet and the culture supernatant,
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consistent with a possible role of the PHS vinyl ether in
PHS detoxification.
Because intra- and extracellular levels of both PHS and
PHS vinyl ether were comparable, it is conceivable that export of these lipids occurs by passive, energy-independent
transport pathways. PHS export, on the other hand, has
previously been described to be ATP dependent and to rely
on Rsb1, a seven transmembrane protein, whose overexpression rescues the LCB sensitivity of dpl1 mutant cells
(54, 55). To examine the energy requirement of the export
of the vinyl ether, we challenged dpl1 mutant cells overexpressing RSB1 with C17-PHS for 20 min, switched cells to
medium containing 2-deoxyglucose and NaN3/NaF to deplete ATP levels for 15 min, and then analyzed C17-PHS
and C17-PHS vinyl ether levels in the cell pellet and the
culture supernatant. Levels of both C17-PHS and that of the
C17-PHS vinyl ether in the extracellular medium dropped
significantly upon energy depletion of the cells, consistent
with the notion that the export of both of these LCBs is dependent on an active, energy-requiring process (Fig. 7B).
Taken together, the data presented here indicate that
free PHS is efficiently converted to a PHS vinyl ether derivative. This conversion is dependent on acetyl-CoA levels,
and both free PHS and PHS vinyl ether are efficiently excreted by the cells. Based on these observations, we propose that the synthesis of the vinyl ether containing LCB
may act to reduce levels of endogenous free LCBs and thus
relieve cells of the growth inhibition of these LCBs. In this
model, PHS vinyl ether synthesis and its export may thus
act as a detoxification pathway to reduce levels of endogenous PHS (Fig. 8). If this were correct, one would predict
that unlike free PHS, the PHS vinyl ether would not be
taken up by the cells. A prediction that can be tested once
a synthetic PHS vinyl ether will be available. In any case,
conversion of free PHS into the vinyl ether derivative provides an additional means to regulate and fine tune the
levels of free LCBs and thus to sustain cell proliferation
under adverse conditions.
The authors thank J. D. Boeke and T. Dunn for mutant strains;
S. Reddy Polu and S. Schürch for initial analysis of the compound;
A. Conzelmann, T. Hornemann, and S. G. Gowda for helpful
discussions; and S. Cottier for comments on the manuscript.

Fig. 8. Different fates of LCBs. Scheme summarizing the conversions of LCBs into ceramide, the vinyl ether derivative, and
the phosphorylation-dependent catabolic pathway. The open questions of whether the LCB vinyl ether can be converted back into
a free LCB and whether it can be efficiently taken up by the cells
are indicated.
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and then to the vinyl ether (Fig. 6A). This hypothesis would
predict that formation of PHS vinyl ether is decreased in
cells that have low acetyl-CoA levels. Acetyl-CoA can be produced by at least three major pathways in yeast: through the
mitochondrial pyruvate dehydrogenase (PDH) complex,
through peroxisomal -oxidation, and through the two
acetyl-CoA synthetases, Acs1 and Acs2 (46–48). Under aerobic conditions and on glucose-containing media, ACS2 is
essential and ACS1 and the -oxidation genes, e.g., POT1,
are repressed, and the PDH genes are not essential (46, 47,
49). To examine the requirement of acetyl-CoA for the conversion of PHS into PHS vinyl ether, we challenged wildtype and acs mutant cells with externally provided PHS and
monitored the appearance of the vinyl ether. Wild-type and
acs2 mutant cells carrying a plasmid borne copy of ACS2
(acs2 + pACS2) displayed an essentially equimolar ratio
between PHS and PHS vinyl ether (Fig. 6B). The acs2 mutant rescued by a temperature-sensitive (ts) allele of ACS2
(pACS2-1ts) and the acs1 acs2 double mutant carrying the
same ts allele of ACS2, however, displayed significantly decreased levels of PHS vinyl ether compared with free PHS.
These data thus indicate that normal acetyl-CoA levels are
required for the efficient conversion of free PHS into PHS
vinyl ether and hence that vinyl ether formation may proceed through the formation of an O-acetylated LCB intermediate. It is interesting to note that acetylated LCBs are
found in certain microorganisms, such as Wickerhamomyces
ciferrii (50). However, deletion of the acetyltranferases implied in the formation of the W. ciferrii acetylated LCBs,
SLI1 and ATF2, in Saccharomyces cerevisiae did not affect PHS
vinyl ether synthesis (data not shown). In mammals, on the
other hand, 3-O-acetyl-sphingosine is present in so called
fast migrating forms of cerebrosides. They appear during
myelinogenesis and may play critical functions in myelin
structure and function (51). The possibility that PHS vinyl
ether synthesis occurs through an acetylated intermediate
renders its synthesis analogous to that of the mammalian
ether containing glycerophospholipids, which occurs
through the exchange of sn-1 bound acyl group on dihydroxyacetone phosphate by an alkyl group. The resulting
alkyl ether can then be further reduced to a vinyl ether, as
typically found in the plasmalogens (52).
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